Oculis Holding AG (OCS)
23.07
+1.04
(+4.72%)
USD |
NASDAQ |
Jan 09, 16:00
23.01
-0.06
(-0.26%)
After-Hours: 20:00
Oculis EPS Diluted (Quarterly): -0.4022 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 1.092 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
| Addex Therapeutics Ltd. | -2.099 |
| NewCelX Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.06M |
| Total Expenses (Quarterly) | 21.06M |
| Enterprise Value | 1.154B |
| Earnings Yield | -10.92% |
| Normalized Earnings Yield | -9.210 |